<DOC>
	<DOCNO>NCT00161239</DOCNO>
	<brief_summary>Peripheral T cell lymphoma advance cutaneous T cell lymphomas aggressive refractory disease generally treat chemotherapy . Despite current treatment modality , subset patient cure treatment . In study , four chemotherapeutic agent ( L-asparaginase , Methotrexate , Doxil , Prednisone ) administer combination regimen patient relapse refractory Peripheral and/or advance cutaneous T cell lymphoma . Each one individual drug show activity lymphoma . The objective study determine combination chemotherapy agent result high response cure rate patient population . This single institutional study include 32 patient Peripheral T cell lymphoma group 32 patient Cutaneous T cell lymphoma group .</brief_summary>
	<brief_title>LAMPP Trial Peripheral Cutaneous T-Cell Lymphoma</brief_title>
	<detailed_description>Peripheral T cell lymphoma advance cutaneous T cell lymphomas aggressive refractory disease generally treat chemotherapy . Despite current treatment modality , subset patient cure treatment . In study , four chemotherapeutic agent ( L-asparaginase , Methotrexate , Doxil , Prednisone ) administer combination regimen patient relapse refractory Peripheral and/or advance cutaneous T cell lymphoma . Each one individual drug show activity lymphoma . The objective study determine combination chemotherapy agent result high response cure rate patient population . This single institutional study include 32 patient Peripheral T cell lymphoma group 32 patient Cutaneous T cell lymphoma group .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Inclusion : Patients must least 18 year age . Histologically confirm ( include immunohistochemistry ) diagnosis TCell Lymphoma skin biopsy visceral/lymph node biopsy bone marrow aspirate/biopsy Life expectancy 3 month . Exclusion : Uncontrolled diabetes mellitus Active serious infection uncontrolled antibiotic Concurrent treatment , radiation investigational treatment . 5.2.6 Significant underlying cardiac disease , include unstable angina , myocardial infarction le 6 month start study , congestive failure cause</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>T-Cell Lymphomas</keyword>
</DOC>